Cufstik AM Junior Syrup contains Ambroxol 10 mg, Terbutaline 0.5 mg, and Guaiphenesin 25 mg, a triple-action pediatric respiratory formulation designed to manage productive cough, chest congestion, and breathing difficulty in children.
Ambroxol acts as a mucolytic, thinning thick mucus and facilitating easy expectoration. Terbutaline works as a bronchodilator, relaxing airway smooth muscles to improve airflow, while Guaiphenesin functions as an expectorant, helping clear mucus from the respiratory tract.
Clinically, Cufstik AM Junior Syrup is indicated for acute and chronic cough, bronchitis, lower respiratory tract infections, and wheezing associated with mucus buildup, providing effective symptom relief and improved breathing comfort.
The syrup formulation ensures easy administration, accurate dosing, and better pediatric compliance, making it suitable for routine use in pediatric and general practice respiratory care.